Raymond James Financial Inc. Acquires New Shares in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Raymond James Financial Inc. purchased a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 129,486 shares of the company’s stock, valued at approximately $5,134,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Blue Trust Inc. lifted its stake in Acadia Healthcare by 69.4% during the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock valued at $33,000 after acquiring an additional 345 shares during the period. Nisa Investment Advisors LLC lifted its position in Acadia Healthcare by 40.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock valued at $41,000 after purchasing an additional 301 shares during the period. Fifth Third Bancorp boosted its holdings in Acadia Healthcare by 56.0% in the fourth quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock worth $50,000 after purchasing an additional 454 shares during the last quarter. GAMMA Investing LLC grew its position in Acadia Healthcare by 259.6% in the 4th quarter. GAMMA Investing LLC now owns 2,384 shares of the company’s stock worth $95,000 after purchasing an additional 1,721 shares during the period. Finally, Quarry LP raised its stake in Acadia Healthcare by 2,729.0% during the 3rd quarter. Quarry LP now owns 1,754 shares of the company’s stock valued at $111,000 after buying an additional 1,692 shares during the last quarter.

Acadia Healthcare Stock Performance

Shares of NASDAQ ACHC opened at $28.81 on Wednesday. The stock has a market cap of $2.68 billion, a PE ratio of 9.45, a price-to-earnings-growth ratio of 1.46 and a beta of 1.38. Acadia Healthcare Company, Inc. has a 1 year low of $27.61 and a 1 year high of $82.41. The firm has a fifty day moving average price of $37.92 and a 200-day moving average price of $45.82. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Analyst Upgrades and Downgrades

Several analysts recently commented on ACHC shares. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $45.00 to $75.00 in a report on Thursday, December 12th. KeyCorp reduced their price target on shares of Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating for the company in a research report on Monday, March 3rd. StockNews.com downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. Mizuho reduced their target price on shares of Acadia Healthcare from $48.00 to $37.00 and set a “neutral” rating for the company in a report on Tuesday. Finally, TD Cowen cut their price objective on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, three have issued a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $52.19.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.